A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if a paclitaxel-cisplatin combination
regimen given in the neoadjuvant setting is active in locally advanced head and neck cancer.
the safety of this treatment will also be studied.